Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
about
Vector transmission of leishmania abrogates vaccine-induced protective immunityDifferences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discoveryWhat's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunityVaccines for the leishmaniases: proposals for a research agendaIdentifying vaccine targets for anti-leishmanial vaccine developmentSynthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccinesInfection parameters in the sand fly vector that predict transmission of Leishmania majorKSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqiLeishmania manipulation of sand fly feeding behavior results in enhanced transmission.The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host.Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection.Natural transmission of Leishmania infantum through experimentally infected Phlebotomus perniciosus highlights the virulence of Leishmania parasites circulating in the human visceral leishmaniasis outbreak in Madrid, SpainLive attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 miceA new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand fliesQuantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies.The skin as interface in the transmission of arthropod-borne pathogens.Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies.Experimental models in vaccine research: malaria and leishmaniasis.Carbohydrate-based vaccines: challenges and opportunities.Toward automated oligosaccharide synthesis.Leishmania vaccine development: exploiting the host-vector-parasite interface.A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.Solid-Phase Synthesis of Fluorinated Analogues of Glycosyl 1-Phosphate Repeating Structures from Leishmania using the Phosphoramidite Method.
P2860
Q27316727-A1D7A286-B22B-4778-BB11-B17213723CCAQ28077110-50A0AA61-317C-435C-93B3-629ABC0B242EQ28607896-E573E97E-9C42-4FD6-B351-E76684E9AC36Q28741577-B9C53CDD-5007-4415-AE89-F57010048EBBQ33693899-F16E8E78-1D2F-47D9-8B34-887859D5B392Q33870163-C3FEC4CE-520A-4451-86AC-9CE23EDBDBB7Q34009085-F02A659B-34BF-457B-B13F-FEF41201D461Q34235741-D48B6986-C1EE-40FE-B56D-B5859E20A0E7Q35865489-910A8B34-3AFA-4843-87D1-77B199FA3DDFQ36063617-B4A43ACC-7712-45E6-A43D-651EF9747F5AQ36288318-BDEF816C-895C-4442-9987-D57AE21A4CB6Q36357924-464C1976-D0EB-4E2B-A01B-D18C68B793B7Q36625975-55878327-2189-4045-94B3-F8E9D833ED7AQ36682576-721C1C54-5DC5-46EC-94C6-DCF6D4CD3CB4Q36702606-65E12335-A77B-44F6-9C6D-CFF59FCF19A0Q36787010-24500385-5DCC-4B52-9455-28E0EA740678Q36816174-714A59E8-2EF1-4868-BFB8-4BF01AA5E4D3Q36828370-C66B7660-0A8E-43B7-A750-0491F15D3873Q37371348-A3621E0A-4220-4887-8547-642804941832Q37810597-BE1F5E39-18AE-45C8-B00A-398DBC3B5BBFQ37962848-6910AFF7-81A5-45EB-9442-E12383E6D249Q38643410-FEA5E6D0-3273-4169-9AA3-71C812DD1A41Q41186389-3845BF4F-2265-4C8D-ADE4-C7C95311117CQ46275091-1A09AF2C-A1C3-4907-9D70-1E12FD3B6B02Q55222446-B0FC2218-2AF8-4760-8DC4-A471E4D2C2DB
P2860
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@ast
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@en
type
label
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@ast
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@en
prefLabel
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@ast
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.
@en
P2093
P2860
P356
P1476
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies
@en
P2093
Andrei V Nikolaev
Matthew E Rogers
Olga V Sizova
P2860
P304
P356
10.1086/505584
P407
P577
2006-07-03T00:00:00Z